Relay Therapeutics, Inc.

NasdaqGM:RLAY Stock Report

Market Cap: US$1.1b

Relay Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:RLAY Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
29 Jan 24SellUS$19,328Thomas CatinazzoIndividual2,005US$9.64
29 Jan 24SellUS$15,916Peter RahmerIndividual1,651US$9.64
29 Jan 24SellUS$18,596Brian AdamsIndividual1,929US$9.64
29 Jan 24SellUS$30,636Donald BergstromIndividual3,178US$9.64
27 Dec 23SellUS$3,384Brian AdamsIndividual294US$11.51
27 Dec 23SellUS$11,245Donald BergstromIndividual977US$11.51
27 Dec 23SellUS$3,384Thomas CatinazzoIndividual294US$11.51
27 Dec 23SellUS$2,808Peter RahmerIndividual244US$11.51
30 Oct 23SellUS$9,841Brian AdamsIndividual1,632US$6.03
30 Oct 23SellUS$20,810Donald BergstromIndividual3,451US$6.03
30 Oct 23SellUS$10,233Thomas CatinazzoIndividual1,697US$6.03
30 Oct 23SellUS$8,165Peter RahmerIndividual1,354US$6.03
27 Sep 23SellUS$2,464Brian AdamsIndividual294US$8.38
27 Sep 23SellUS$5,430Donald BergstromIndividual648US$8.38
27 Sep 23SellUS$2,464Thomas CatinazzoIndividual294US$8.38
27 Sep 23SellUS$2,045Peter RahmerIndividual244US$8.38
28 Jul 23SellUS$19,210Brian AdamsIndividual1,628US$11.80
28 Jul 23SellUS$31,659Donald BergstromIndividual2,683US$11.80
28 Jul 23SellUS$19,977Thomas CatinazzoIndividual1,693US$11.80
28 Jul 23SellUS$15,954Peter RahmerIndividual1,352US$11.80
27 Jun 23SellUS$3,563Brian AdamsIndividual294US$12.12
27 Jun 23SellUS$7,842Donald BergstromIndividual647US$12.12
27 Jun 23SellUS$3,563Thomas CatinazzoIndividual294US$12.12
27 Jun 23SellUS$2,957Peter RahmerIndividual244US$12.12
28 Apr 23SellUS$21,606Brian AdamsIndividual1,936US$11.16
28 Apr 23SellUS$31,806Donald BergstromIndividual2,850US$11.16
28 Apr 23SellUS$22,454Thomas CatinazzoIndividual2,012US$11.16
28 Apr 23SellUS$18,492Peter RahmerIndividual1,657US$11.16

Insider Trading Volume

Insider Buying: RLAY insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of RLAY?
Owner TypeNumber of SharesOwnership Percentage
Public Companies4,5800.00349%
Private Companies17,4000.0133%
General Public145,3420.111%
Individual Insiders2,850,8592.17%
VC/PE Firms35,292,90626.9%
Institutions92,867,94770.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.1%.


Top Shareholders

Top 25 shareholders own 84.83% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
21.3%
SoftBank Investment Advisers (UK) Limited
27,904,963US$227.7m0%1.32%
8.12%
The Vanguard Group, Inc.
10,650,387US$86.9m0.93%no data
7.3%
BlackRock, Inc.
9,573,423US$78.1m14.9%no data
7.16%
T. Rowe Price Group, Inc.
9,395,981US$76.7m-13.6%0.01%
5.63%
Casdin Capital, LLC
7,387,943US$60.3m6.71%4.66%
4.53%
Bellevue Asset Management AG
5,936,082US$48.4m21.5%0.5%
4.34%
JP Morgan Asset Management
5,692,978US$46.5m14.8%0.01%
3.74%
State Street Global Advisors, Inc.
4,903,578US$40.0m-0.06%no data
3.03%
BVF Partners L.P.
3,970,045US$32.4m67.8%0.69%
2.98%
ArrowMark Colorado Holdings, LLC
3,914,246US$31.9m2.72%0.33%
2.34%
Norges Bank Investment Management
3,068,973US$25.0m71.6%no data
1.59%
Geode Capital Management, LLC
2,081,510US$17.0m5.61%no data
1.39%
Tavistock Life Sciences
1,819,132US$14.8m0%0.78%
1.28%
Jacobs Levy Equity Management Inc
1,684,299US$13.7m403%0.06%
1.19%
GV Management Company, LLC
1,564,173US$12.8m0%1.01%
1.11%
FMR LLC
1,454,943US$11.9m-31%no data
1.04%
Sanjiv Patel
1,363,565US$11.1m0%no data
1.04%
Dimensional Fund Advisors LP
1,359,155US$11.1m33.6%no data
1.03%
Nextech Invest Ltd.
1,346,409US$11.0m12.5%1.89%
1%
Finepoint Capital LP
1,317,870US$10.8m51.3%3.39%
0.88%
Baker Bros. Advisors LP
1,160,117US$9.5m0%0.11%
0.78%
UBS Asset Management AG
1,028,165US$8.4m11%no data
0.76%
Mark Murcko
996,952US$8.1m0%no data
0.67%
Charles Schwab Investment Management, Inc.
877,813US$7.2m22.8%no data
0.63%
BioImpact Capital LLC
832,017US$6.8m-38.5%1.27%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.